MX9101035A - Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene - Google Patents

Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene

Info

Publication number
MX9101035A
MX9101035A MX9101035A MX9101035A MX9101035A MX 9101035 A MX9101035 A MX 9101035A MX 9101035 A MX9101035 A MX 9101035A MX 9101035 A MX9101035 A MX 9101035A MX 9101035 A MX9101035 A MX 9101035A
Authority
MX
Mexico
Prior art keywords
quinazolinones
pharmaceutical composition
composition containing
biologically active
biologically
Prior art date
Application number
MX9101035A
Other languages
English (en)
Inventor
Jefferson Ray Mccowan
Kenneth Jeff Thrasher
Melvin Joseph Yu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9101035A publication Critical patent/MX9101035A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
MX9101035A 1990-09-13 1991-09-11 Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene MX9101035A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/581,943 US5075313A (en) 1990-09-13 1990-09-13 3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof

Publications (1)

Publication Number Publication Date
MX9101035A true MX9101035A (es) 1992-05-04

Family

ID=24327210

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9101035A MX9101035A (es) 1990-09-13 1991-09-11 Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene

Country Status (20)

Country Link
US (1) US5075313A (es)
EP (1) EP0475755B1 (es)
JP (1) JPH04247080A (es)
KR (1) KR920006350A (es)
CN (1) CN1059722A (es)
AU (1) AU641043B2 (es)
CA (1) CA2050994A1 (es)
CZ (1) CZ279774B6 (es)
DE (1) DE69113379T2 (es)
ES (1) ES2078455T3 (es)
FI (1) FI914262A (es)
HU (1) HUT59128A (es)
IE (1) IE913217A1 (es)
IL (1) IL99402A0 (es)
MX (1) MX9101035A (es)
NO (1) NO913579L (es)
NZ (1) NZ239712A (es)
PT (1) PT98915A (es)
YU (1) YU151691A (es)
ZA (1) ZA917149B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340801A (en) * 1991-05-08 1994-08-23 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having cholecystokinin and gastrin antagonistic properties
US5204354A (en) * 1992-02-14 1993-04-20 Merck & Co., Inc. Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders
GB0031315D0 (en) * 2000-12-21 2001-02-07 Glaxo Group Ltd Indole derivatives
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
JP5137228B2 (ja) 2003-03-07 2013-02-06 メルク・シャープ・アンド・ドーム・コーポレーション 高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用
DE602004018617D1 (de) 2003-03-07 2009-02-05 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US7348338B2 (en) * 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
EP1648867B1 (en) 2003-07-17 2013-09-04 Plexxikon Inc. Ppar active compounds
GB0319126D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
CA2589896A1 (en) * 2004-11-30 2006-06-08 Plexxikon, Inc. Indole derivatives for use as ppar active compounds
JP2008521829A (ja) * 2004-11-30 2008-06-26 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
CA2621406A1 (en) * 2005-09-07 2007-03-15 Plexxikon, Inc. Pparactive compounds
JP2009509932A (ja) * 2005-09-07 2009-03-12 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
JP2009514954A (ja) * 2005-11-04 2009-04-09 ハイドラ バイオサイエンシズ インコーポレイテッド Ｔｒｐｖ３機能を変調するための化合物
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
CA3168103A1 (en) 2020-01-29 2021-08-05 Kamari Pharma Ltd. Compounds and compositions for use in treating skin disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
EP0336356A3 (en) * 1988-04-05 1991-09-25 Abbott Laboratories Derivatives of tryptophan as cck antagonists

Also Published As

Publication number Publication date
IL99402A0 (en) 1992-08-18
NZ239712A (en) 1993-06-25
PT98915A (pt) 1992-08-31
JPH04247080A (ja) 1992-09-03
HU912921D0 (en) 1992-01-28
AU641043B2 (en) 1993-09-09
DE69113379D1 (de) 1995-11-02
CZ279774B6 (cs) 1995-06-14
FI914262A (fi) 1992-03-14
KR920006350A (ko) 1992-04-27
YU151691A (sh) 1994-01-20
CA2050994A1 (en) 1992-03-14
DE69113379T2 (de) 1996-03-21
AU8382991A (en) 1992-03-19
EP0475755A1 (en) 1992-03-18
NO913579L (no) 1992-03-16
EP0475755B1 (en) 1995-09-27
HUT59128A (en) 1992-04-28
FI914262A0 (fi) 1991-09-10
US5075313A (en) 1991-12-24
IE913217A1 (en) 1992-02-25
NO913579D0 (no) 1991-09-11
ZA917149B (en) 1992-05-27
CS279991A3 (en) 1992-04-15
ES2078455T3 (es) 1995-12-16
CN1059722A (zh) 1992-03-25

Similar Documents

Publication Publication Date Title
BR1100824A (pt) Composto e composição farmacêutica
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
DE69233474D1 (de) Pharmazeutische Zusammensetzung enthaltend S-Nitrosoimmunoglobuline und Verwendung davon
DE3486441T2 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
IT9022032A0 (it) L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
NO930677L (no) Farmasoeytiske forbindelser
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
FI925778A0 (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
KR950701924A (ko) 신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법
DE4294862T1 (de) Pharmazeutische Komposition
NO931008D0 (no) Farmasoeytiske forbindelser
DE69323568D1 (de) Antimikrobielle Zusammensetzungen und pharmazeutische Präparate hiervon
UA26064A1 (uk) Фармацевтичhа композиція
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
DK0511991T3 (da) Farmaceutisk formulering
NO306381B1 (no) Farmasöytisk ampulle
DE59003130D1 (de) Mikrobizid-Formulierungen und deren Verwendung.
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
DE69117519D1 (de) 14-o-p-chlorbenzoylaconin und analgetischer/entzündungshemmender wirkstoff
DE69130611T2 (de) Hydroxycholesterol enthaltende pharmazeutsiche zusammensetzungen und deren verwendung in medikamenten
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
IT9048244A0 (it) Composizione farmaceutica ad effetto cicatrizzante.